Literature DB >> 33708108

Pueraria tuberosa: A Review on Traditional Uses, Pharmacology, and Phytochemistry.

Ram Bharti1,2, Bhupinder Singh Chopra1,2, Sachin Raut1,2, Neeraj Khatri1,2.   

Abstract

Pueraria tuberosa (Roxb. ex Willd.) DC. (Fabaceae), also known as Indian Kudzu (vidari kand), is a perennial herb distributed throughout India and other Asian countries. Traditionally, tuber and leaves of this plant have extensively been reported for nutritional and medicinal properties in Ayurveda as well as in Chinese traditional practices. The objective of the present review is to compile and update the published data on traditional uses, pharmacological potential, and phytochemistry of compounds isolated from the plant Pueraria tuberosa. P. tuberosa extracts and its purified compounds possess multiple activities such as anticancer, anticonvulsant, antidiabetic, antifertility, anti-inflammatory, antioxidant, anti-stress, antiulcerogenic, cardioprotective, hypolipidemic, hepatoprotective, immunomodulatory, nephroprotective, nootropic, neuroprotective, and wound healing. Tuber and leaf extracts of P. tuberosa contain several bioactive constituents such as puerarin, daidzein, genistein, quercetin, irisolidone, biochanin A, biochanin B, isoorientin, and mangiferin, which possess an extensive range of pharmacological activities. The extensive range of pharmacological properties of P. tuberosa provides opportunities for further investigation and presents a new approach for the treatment of ailments. Many phytochemicals have been identified and characterized from P. tuberosa; however, some of them are still unexplored, and there is no supporting data for their activities and exact mechanisms of action. Therefore, further investigations are warranted to unravel the mechanisms of action of individual constituents of this plant.
Copyright © 2021 Bharti, Chopra, Raut and Khatri.

Entities:  

Keywords:  Pueraria tuberosa; in vivo studies; pharmacological properties; phytochemical constituents; traditional uses

Year:  2021        PMID: 33708108      PMCID: PMC7941752          DOI: 10.3389/fphar.2020.582506

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  5 in total

1.  Chitosan@Puerarin hydrogel for accelerated wound healing in diabetic subjects by miR-29ab1 mediated inflammatory axis suppression.

Authors:  Xiaoling Zeng; Baohui Chen; Luping Wang; Yingxiao Sun; Zhao Jin; Xuanyong Liu; Liping Ouyang; Yun Liao
Journal:  Bioact Mater       Date:  2022-05-11

Review 2.  Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer.

Authors:  Meizhu He; Lijie Xia; Jinyao Li
Journal:  Biomolecules       Date:  2021-10-18

3.  Structural characterization, anti-inflammatory and glycosidase inhibitory activities of two new polysaccharides from the root of Pueraria lobata.

Authors:  Jiale Cai; Xiaoting Zhong; Jiayin Liang; Can Xu; Huanzheng Yu; Minghua Xian; Chunyan Yan; Shumei Wang
Journal:  RSC Adv       Date:  2021-11-08       Impact factor: 4.036

4.  Puerarin Attenuates Oxidative Stress and Ferroptosis via AMPK/PGC1α/Nrf2 Pathway after Subarachnoid Hemorrhage in Rats.

Authors:  Yi Huang; Honggang Wu; Yongmei Hu; Chenhui Zhou; Jiawei Wu; Yiwen Wu; Haifeng Wang; Cameron Lenahan; Lei Huang; Sheng Nie; Xiang Gao; Jie Sun
Journal:  Antioxidants (Basel)       Date:  2022-06-27

5.  Antioxidant and Cytotoxic Activities of Kudzu Roots and Soy Molasses against Pediatric Tumors and Phytochemical Analysis of Isoflavones Using HPLC-DAD-ESI-HRMS.

Authors:  Saied A Aboushanab; Vadim A Shevyrin; Grigory P Slesarev; Vsevolod V Melekhin; Anna V Shcheglova; Oleg G Makeev; Elena G Kovaleva; Ki Hyun Kim
Journal:  Plants (Basel)       Date:  2022-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.